HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $3 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Icecure Medical (NASDAQ:ICCM) and maintained a price target of $3.
August 15, 2023 | 10:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Icecure Medical's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $3.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $3 indicates the firm's continued confidence in the company's potential. This could lead to increased investor interest and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100